Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

    Not recruiting

    3 1 1 1
    Belgium Czechia France Germany Greece Hungary +5
  • Study of iberdomide alone or with drug combinations for patients with multiple myeloma: testing safety and effectiveness of different doses

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    France Germany Italy The Netherlands Spain
  • Study of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Greece Italy Spain
  • Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark France Germany +6
  • Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Estonia Norway
  • Study on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Denmark France Germany Italy Spain
  • Study on Venetoclax, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Hungary Spain
  • Study of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Greece +7
  • Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Czechia France Germany The Netherlands Poland Spain